Quick Answer
Annovis Bio, Inc. reported Shares Outstanding of 27.20 million shares for fiscal year 2025.
Annovis Bio, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 27.20M | +92.3% |
| 2024 | 14.14M | +34.4% |
| 2023 | 10.52M | +28.9% |
| 2022 | 8.16M | +0.0% |
| 2022 | 8.16M | +0.0% |
| 2022 | 8.16M | +0.0% |
| 2022 | 8.16M | +0.8% |
| 2021 | 8.10M | +17.5% |
| 2020 | 6.89M | +2338.5% |
| 2019 | 282,614 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 20.19M | +52.0% | +3.6% |
| June 30, 2025 | 19.49M | +66.2% | +0.0% |
| March 31, 2025 | 19.49M | +77.0% | +37.8% |
| December 31, 2024 | 14.14M | +34.4% | +6.5% |
| September 30, 2024 | 13.28M | +47.4% | +13.3% |
| June 30, 2024 | 11.72M | +30.1% | +6.4% |
| March 31, 2024 | 11.01M | +34.0% | +4.7% |
| December 31, 2023 | 10.52M | +28.9% | +16.7% |
- Annovis Bio, Inc. showed an increase of +92.3% in Shares Outstanding compared to the prior fiscal year.
- Over the 2019–2025 period, Annovis Bio, Inc.’s shares outstanding has grown by 9524.1% (from 282.6 thousand shares to 27.20 million shares).
- The most recent figure is from Annovis Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: